Background: In COVID-19 pneumonia, chest CT scan plays a crucial role in diagnosing and closely monitoring lung parenchyma. The main reportedly chest CT features of novel coronavirus pneumonia (NCP) have been fully discussed in the literature, but there is still a paucity of reports on uncommon CT manifestations.
Case Presentation: Herewith, we have reported ten rRT-PCR confirmed COVID-19 patients with CT target signs (bull's eye appearance); additionally, we have reviewed previously reported cases. Reviewing the literature, we found eight COVID-19 patients with target sign in the literature. 18 patients were included with a median age of 43. 11 (61%) patients were males. In 87% of patients, the lesions developed within the second-week post symptom onset. These patients mostly experienced an extended hospital stay (median = 10 days), with 53.8% of cases being admitted in ICU. The in-hospital mortality rate was 23%.
Conclusion: Our findings indicate that lesions with a bull's eye appearance are not significantly associated with higher mortality in hospitalized COVID-19 patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272949 | PMC |
http://dx.doi.org/10.22088/cjim.13.0.270 | DOI Listing |
J Cardiovasc Imaging
December 2024
Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Republic of Korea.
Background: Evaluation of regional left ventricle function using two-dimensional echocardiography (2DE) in patients with ischemic heart disease has limitations due to its low objectivity and qualitative nature. In addition, 2DE is limited because multiple acoustic windows are used to obtain the image, whereas three-dimensional echocardiography (3DE) uses a single window. This study aims to demonstrate the clinical utility of 3DE segmental volume analysis for evaluating regional wall motion abnormality (RWMA).
View Article and Find Full Text PDFBMC Cardiovasc Disord
December 2024
Cardiology Department, Royal Albert Edward Infirmary, WWL NHS Trust, Wigan, UK.
Background: Concomitant cardiac amyloidosis (CA) and aortic stenosis (AS) may be mistaken for isolated AS, potentially impacting the treatment strategy and patient's prognosis. Therefore, it is crucial to distinguish between these conditions, as failure to promptly diagnose CA may lead to considerable complications. The aim of this study is to investigate the diagnostic value of strain predictors in patients with concomitant CA and AS compared to isolated AS.
View Article and Find Full Text PDFIndian J Anaesth
November 2024
Consultant Cardiac Anesthesiologist, Pinnacle Hospitals, Health City, Chinna Gadhili, Hanumanthavaka, Vishakhapatnam, Andhra Pradesh, India.
Am J Case Rep
December 2024
Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia.
BACKGROUND Amyloidosis is a group of diseases characterized by the pathological deposition of misfolded proteins in various organs, including the heart, leading to structural and functional alterations. The primary types of cardiac amyloidosis are light chain amyloidosis and transthyretin amyloidosis. Early diagnosis is critical for effective management.
View Article and Find Full Text PDFJ Chem Phys
December 2024
Max Planck Institute for Intelligent Systems, Heisenbergstraße 3, D-70569 Stuttgart, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!